Skip to main content
Egyptian Journal of Medical Human Genetics
Fig. 7 | Egyptian Journal of Medical Human Genetics

Fig. 7

From: Momordica charantia nanoparticles potentiate insulin release and modulate antioxidant gene expression in pancreas of diabetic rats

Fig. 7

a Effects of M. charantia nanoparticles on serum triglyceride. Effects of M. charantia nanoparticles on serum hyperlipidemia. LDL level was determined in the serum of diabetic rats as described in “Methods” section. Values are mean ± SEM of five experimental animals (n = 5). * represents significant difference (p < 0.05) to control, while # represents significant difference (p < 0.05) to STZ (diabetic control) group. b Effects of M. charantia nanoparticles on serum cholesterol. Effects of M. charantia nanoparticles on serum hyperlipidemia. LDL level was determined in the serum of diabetic rats as described in “Methods” section. Values are mean ± SEM of five experimental animals (n = 5). * represents significant difference (p < 0.05) to control, while # represents significant difference (p < 0.05) to STZ (diabetic control) group. c Effects of M. charantia nanoparticles on serum HDL. Effects of M. charantia nanoparticles on serum hyperlipidemia. LDL level was determined in the serum of diabetic rats as described in “Methods” section. Values are mean ± SEM of five experimental animals (n = 5). * represents significant difference (p < 0.05) to control, while # represents significant difference (p < 0.05) to STZ (diabetic control) group. d Effects of M. charantia nanoparticles on serum LDL. Effects of M. charantia nanoparticles on serum hyperlipidemia. LDL level was determined in the serum of diabetic rats as described in “Methods” section. Values are mean ± SEM of five experimental animals (n = 5). * represents significant difference (p < 0.05) to control, while # represents significant difference (p < 0.05) to STZ (diabetic control) group

Back to article page